| |
|
|
|
Intec Pharma Ltd.  
|
|
4.3 -0.15 (-0.03%) |
09-21 16:00 |
|
Open: |
4.55 |
Pre close: |
4.45 |
Target:
|
5.78
|
|
High: |
4.6 |
Low: |
4.15 |
Resistance:
|
4.95
5.78
|
|
Volume: |
255,492 |
Market Cap: |
143M |
Support:
|
4.08
3.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.14
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
3.90 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
4.36  |
Stochastic Oscillator |
%K(14,3):
|
58.33 |
|
MA(250): |
5.67 |
%D(3): |
53.17 |
|
Average Volume(K) |
3-Month: |
9552
|
52-Week |
High:
|
9.80 |
|
10-Days: |
20690 |
Low: |
3.55 |
|
RSI |
RSI(14):
|
59.68 |
Change(%): |
-54.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.540 |
Return on Equity (ttm) |
-83.3 |
Shares Out. (M) |
33.23 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-73.7 |
Shares Float (M) |
33.23 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
36.40 |
|
Forward EPS |
-1.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
304 |
|
Book Value (p.s.) |
1.760 |
EBITDA (p.s.) |
-0.215 |
P/E |
-2.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.44 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.46 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-23.14 |
P/CF |
-4.27 |
|
|
|
|
|
|
